Bernard Toupas
Direktor/Vorstandsmitglied bei goetzpartners Corporate Finance GmbH
Ursprung des Netzwerks ersten Grades von Bernard Toupas
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
goetzpartners Corporate Finance GmbH
 goetzpartners Corporate Finance GmbH Investment ManagersFinance Part of goetzpartners Group GmbH & Co. KG, goetzpartners Corporate Finance GmbH is a Munich-based independent advisory firm that specializes in strategy, M&A, and transformation for entrepreneurial activities. goetzpartners' unique approach combines corporate finance and management consulting to create sustainable added value for clients in determining valid courses of action, reaching decisions, and implementing them. The German company was founded in 1991 by Stefan Sanktjohanser and Stephan Goetz, who have been the CEOs since then.
2
| Subsidiary | Investment Managers | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Bernard Toupas
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
goetzpartners Management Consultants GmbH
 goetzpartners Management Consultants GmbH Miscellaneous Commercial ServicesCommercial Services goetzpartners Management Consultants GmbH provides strategic management consulting services. It specializes in the areas of realignment, sales optimization, restructuring, and post merger integration. The company is headquartered in Munich, Germany. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer | |
| I:FAO AKTIENGESELLSCHAFT | Information Technology Services | Chairman | |
ITM Isotope Technologies Munich SE
 ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology ITM Isotope Technologies Munich SE is a leading radiopharmaceutical biotech company based in Garching, Germany. The German company aims to meet the needs of cancer patients, clinicians, and partners through excellence in development, production, and supply. ITM Isotope Technologies Munich SE strives to provide patients with more effective targeted treatment to improve clinical outcomes and quality of life. ITM is dedicated to providing a new generation of radiomolecular precision therapeutics and diagnostics for hard-to-treat tumors. With a broad precision oncology pipeline, including two phase III studies, ITM combines high-quality radioisotopes with a range of targeting molecules. The company was founded in 2004, and Steffen Schuster has been the CEO since 2011. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Deutschland | 4 |
Sektoral
| Commercial Services | 2 |
| Technology Services | 2 |
| Health Technology | 2 |
Operativ
| Chief Executive Officer | 4 |
| Founder | 2 |
| Chairman | 1 |
| Director/Board Member | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Stefan Sanktjohanser | 4 |
| Stephan Goetz | 2 |
- Börse
- Insiders
- Bernard Toupas
- Unternehmensverbindungen
